Trend tests across ordered categories indicated a monotonic association between adherence level and several baseline risk characteristics (P for trend = 0.018); patients with lower adherence tended to be older, have more advanced tumor stage, and exhibit higher comorbidity burden, indicating a statistical trend between adherence levels and these baseline profiles.
← all excerpts
Adherence to endocrine therapy and survival outcomes in hormone receptor-positive breast cancer.
1
—
—